Insight Molecular Diagnostics Inc. Cash Flow-to-Debt Ratio
Insight Molecular Diagnostics Inc. cash flow-to-debt ratio. Insight Molecular Diagnostics Inc. (IMDX) has a Cash Flow-to-Debt Ratio of -0.18x as of June 2026, meaning its operating cash flow of $-9.27 Million could theoretically repay 0% of its total liabilities ($50.74 Million) in one year. Check Insight Molecular Diagnostics Inc. total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Insight Molecular Diagnostics Inc. (2013–2025)
Cash flow-to-debt ratio of Insight Molecular Diagnostics Inc. from 2013 to 2025. Historical debt coverage capacity for Insight Molecular Diagnostics Inc. across 13 annual periods. Check Insight Molecular Diagnostics Inc. (IMDX) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Insight Molecular Diagnostics Inc. Cash Flow-to-Debt Ratio by Year (2013–2025)
Insight Molecular Diagnostics Inc. cash flow-to-debt ratio by year from 2013 to 2025. Year-by-year debt coverage analysis for Insight Molecular Diagnostics Inc.. For the full cash flow conversion analysis, see how efficiently does Insight Molecular Diagnostics Inc. generate cash.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.39x | $-22.18 Million | $57.22 Million | ▲ +11.4% |
| 2024 | -0.44x | $-20.71 Million | $47.35 Million | ▼ -2.1% |
| 2023 | -0.43x | $-23.32 Million | $54.42 Million | ▲ +43.1% |
| 2022 | -0.75x | $-45.57 Million | $60.50 Million | ▼ -97.7% |
| 2021 | -0.38x | $-35.94 Million | $94.35 Million | ▲ +67.8% |
| 2020 | -1.18x | $-25.98 Million | $21.94 Million | ▲ +45.8% |
| 2019 | -2.19x | $-19.71 Million | $9.02 Million | ▼ -14.3% |
| 2018 | -1.91x | $-11.65 Million | $6.09 Million | ▲ +17.0% |
| 2017 | -2.30x | $-13.38 Million | $5.81 Million | ▼ -40.4% |
| 2016 | -1.64x | $-7.52 Million | $4.58 Million | ▲ +10.2% |
| 2015 | -1.83x | $-4.23 Million | $2.31 Million | ▼ -1066.6% |
| 2014 | -0.16x | $-1.16 Million | $7.43 Million | ▼ -3.1% |
| 2013 | -0.15x | $-710.00K | $4.67 Million | — |